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Abstract
Zebrafish have recently emerged as an attractive in vivo model for epilepsy. Seven-day-old zebrafish larvae exposed to the
GABAA antagonist pentylenetetrazol (PTZ) exhibit increased locomotor activity, seizure-like behavior, and epileptiform
electrographic activity. A previous study showed that 12 out of 13 antiepileptic drugs (AEDs) suppressed PTZ-mediated
increases in larval movement, indicating the potential utility of zebrafish as a high-throughput in vivo model for AED
discovery. However, a question remained as to whether an AED-induced decrease in locomotion is truly indicative of
anticonvulsant activity, as some drugs may impair larval movement through other mechanisms such as general toxicity or
sedation. We therefore carried out a study in PTZ-treated zebrafish larvae, to directly compare the ability of AEDs to inhibit
seizure-like behavioral manifestations with their capacity to suppress epileptiform electrographic activity. We re-tested the
13 AEDs of which 12 were previously reported to inhibit convulsions in the larval movement tracking assay, administering
concentrations that did not, on their own, impair locomotion. In parallel, we carried out open-field recordings on larval
brains after treatment with each AED. For the majority of AEDs we obtained the same response in both the behavioral and
electrographic assays. Overall our data correlate well with those reported in the literature for acute rodent PTZ tests,
indicating that the larval zebrafish brain is more discriminatory than previously thought in its response to AEDs with
different modes of action. Our results underscore the validity of using the zebrafish larval locomotor assay as a rapid first-
pass screening tool in assessing the anticonvulsant and/or proconvulsant activity of compounds, but also highlight the
importance of performing adequate validation when using in vivo models.
Citation: Afrikanova T, Serruys A-SK, Buenafe OEM, Clinckers R, Smolders I, et al. (2013) Validation of the Zebrafish Pentylenetetrazol Seizure Model: Locomotor
versus Electrographic Responses to Antiepileptic Drugs. PLoS ONE 8(1): e54166. doi:10.1371/journal.pone.0054166
Editor: Harold A. Burgess, National Institutes of Health/NICHD, United States of America
Received July 20, 2012; Accepted December 7, 2012; Published January 14, 2013
Copyright:  2013 Afrikanova et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: No current external funding sources for this study.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: camila.esguerra@pharm.kuleuven.be
. These authors contributed equally to this work.
Introduction
Epilepsy is a common neurological disorder marked by episodic
seizures as a result of abnormal electrical activity in the brain.
About 65 million people worldwide are estimated to have epilepsy
[1]. Many epilepsy patients can be treated effectively with
currently available antiepileptic drugs (AEDs), but in up to 30%
of this patient population adequate seizure control is not achieved
[2]. The condition of patients that show drug-resistant seizures can
sometimes be improved by non-pharmacological treatment, but
even after surgery, 10% of patients continue to experience seizures
[2]. For these reasons, the discovery of novel anticonvulsant
compounds and the subsequent development of new, alternative
AEDs remains an important area of research.
In spite of the fact that the acute pentylenetetrazol (PTZ) rodent
seizure model was developed more than 60 years ago, it is still a
widely used test for evaluating potential anticonvulsant com-
pounds [3]. In mice, subcutaneous (s.c.) PTZ administration
produces a characteristic behavioral pattern of events: ear twitch,
vibrissae twitch, straub tail, myoclonic twitch, forelimb clonus,
falling and tonic hind limb extension [4]. These seizure behaviors
correlate with spiking activity and spike-wave discharges in the
cortex as measured by electroencephalography (EEG) [4].
Although the predictive value of the acute PTZ test is high,
rodent models have certain disadvantages for large-scale screening
applications in comparison with smaller vertebrates, namely:
higher cost, lower throughput, the requirement for appreciable
amounts of compound, as well as regulatory and ethical
considerations.
Zebrafish larvae have recently emerged as a new species for
chemoconvulsant-based models of epilepsy [5–9]. Zebrafish larvae
offer several advantages as an in vivo screening platform for drug
discovery due to their high genetic and physiologic homology to
humans [10]. Per week, a single mating pair of adult zebrafish can
generate up to 200 offspring, which develop rapidly ex utero.
Compounds can be added directly to the surrounding medium
and are absorbed by larvae either through the gastrointestinal
tract, skin or gills. Due to their small size, zebrafish larvae can live
in small volumes, and therefore require only microgram amounts
of compound per test. With regard to anticonvulsant screens,
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medium- to high-throughput screening is possible in 96-well
format using an automated locomotor tracking system for the
quantification of larval movement.
To track changes in brain activity of a small subject such as the
zebrafish larva, local field potential recordings have been the
method of choice [5]. Epileptiform activity recorded from
zebrafish brains includes interictal and ictal-like discharges and
is similar to the neural activity described for hippocampal slice
recordings from rodent brains [5,11]. Interictal-like discharges
recorded from zebrafish larval brains have been described as small
and frequent, while ictal-like discharges possess high amplitude
and occur infrequently [12].
The zebrafish PTZ seizure model has already been partly
described: zebrafish larvae exposed to this chemoconvulsant,
exhibit increased locomotor activity and seizure-like stereotypic
behavior in a concentration-dependent manner [5]. PTZ-treated
larvae show epileptiform electrographic discharges on field
potential recordings from the optic tectum [5,8]. Nevertheless,
the systematic direct comparison between a decreased locomotor
activity in larval zebrafish and true anti-seizure/EEG modulating
activity of AEDs has not yet been reported [7]. Here we study the
effectiveness of 13 AEDs against PTZ-induced increase in
movement and epileptiform electrical activity to assess both the
advantages and limitations of this animal model for primary
screening in drug discovery.
Materials and Methods
Animals
Zebrafish (Danio rerio) stocks of the Ekkwill strain (Ekkwill
Tropical Fish Farm, Gibonston, Florida) were maintained at
28.5uC, on a 14/10 hour light/dark cycle under standard
aquaculture conditions, and fertilized eggs were collected via
natural spawning. Embryos were reared under constant light
conditions in embryo medium: 1.5 mM HEPES, pH 7.6,
17.4 mM NaCl, 0.21 mM KCl, 0.12 mM MgSO4, and
0.18 mM Ca(NO3)2) in an incubator at 28.5uC. In our experi-
mental setup, we found that larvae displayed the most consistent
basal activity levels when raised under constant light conditions.
For all measurements described, larvae of 7 days post-fertilization
(dpf) were used.
All zebrafish experiments carried out were approved by the
Ethics Committee of the University of Leuven (Ethische
Commissie van de KU Leuven, approval number P05090) and
by the Belgian Federal Department of Public Health, Food Safety
& Environment (Federale Overheidsdienst Volksgezondheid,
Veiligheid van de Voedselketen en Leefmileu, approval number
LA1210199).
Drugs
The following anticonvulsants: carbamazepine (CBZ), ethosux-
imide (ETS), oxcarbazepine (OXC), lamotrigine (LTG), levetir-
acetam (LVT), zonisamide (ZSM), primidone (PMD), topiramate
(TPR), and aspirin (ASP; negative control) were purchased from
Sigma. Other AEDs used in this study were: diazepam (DZP;
Roche), gabapentin (GBP; Fluka), tiagabine (TGB; Chemos),
sodium valproate (VPA; Sanofi-Aventis), and phenytoin (PHT;
Acros). All compounds were dissolved in DMSO and diluted in
embryo medium to achieve a final DMSO concentration of 1%
w/v. Embryo medium prepared with DMSO to a final
concentration of 1% w/v served as a vehicle control (VHC).
Pentylenetetrazol was also purchased from Sigma and was
dissolved to 40 mM (2x stock) in embryo medium.
Toxicological Evaluation
Zebrafish larvae were incubated with AEDs at 28.5uC in
complete darkness. After 90 min, each larva was individually
checked under the microscope for the following signs of acute
locomotor impairment: hypoactivity, decreased or no touch/
escape response upon a light touch of the tail with a fine needle
[13,14], loss of posture, body deformation, exophthalmos (bulging
of the eyes out of their sockets), slow or absent heartbeat, and
death. After an overnight incubation (18 hours, 28.5uC, complete
darkness), assessment of larvae for the same above-mentioned signs
of toxicity was repeated. A larva was considered normal if it could
cover a distance twice its body length. A shorter distance travelled
or movement in the same place was scored as a decreased or
impaired touch response. No visible movement upon a touch
stimulus was counted as no response. The MTC was thus defined
as the maximum concentration that did not cause death and
where not more than two out of 12 larvae exhibited any sign of
locomotor impairment including no touch response after an 18-
hour incubation period. A decrease in spontaneous movement
with retained ability to swim away in response to touch was
considered an acceptable AED concentration for further testing.
Evaluation of Anticonvulsant Activity
a) Movement tracking system. Six-dpf larvae were pre-
incubated in 100 ml of AED or VHC for 18 hours in
individual wells of a 96-well plate at 28.5uC in the dark (for
timeline schematic see Figure 1). Ten to twelve larvae were
used per treatment parameter and per experiment. The
concentrations of AEDs used are described in the results
section. After the pre-incubation, 100 ml of embryo medium
or 100 ml of a 40 mM PTZ solution was added to obtain a
final concentration of 20 mM [7,15]. Larvae were allowed to
habituate for 5 min in a dark chamber of an automated
tracking device (ZebraBoxTM apparatus; Viewpoint, Lyon,
France). The total locomotor activity was then quantified
using ZebraLabTM software (Viewpoint, Lyon, France) [15].
Total movement or activity was expressed in ‘‘actinteg’’ units.
The actinteg value of the ZebraLabTM software is defined as
the sum of all image pixel changes detected during the time
slice defined for the experiment. All tracking experiments
were performed at least in triplicate.
b) EEG recordings. Each larva was pre-incubated in 400 ml
of AED or VHC for 18 hours in individual wells of a 24-well
plate at 28.5uC in the dark. An equal volume of 40 mM PTZ
(2x solution) was then added to each well and the larvae were
exposed to the chemoconvulsant for 15 min (Figure 1). A
larva was then embedded in 2% low-melting-point agarose, a
glass electrode filled with artificial cerebrospinal fluid
composed of: 124 mM NaCl, 2 mM KCl, 2 mM MgSO4,
2 mM CaCl2, 1.25 mM KH2PO4, 26 mM NaHCO3 and
10 mM glucose (resistance 1–5 MV), was placed into the
optic tectum and recordings were performed in current clamp
mode, low-pass filtered at 1 kHz, high-pass filtered 0.1 Hz,
digital gain 10, sampling interval 10 ms (MultiClamp 700B
amplifier, Digidata 1440A digitizer, both Axon instruments,
USA). The recordings started each time exactly 5 min after
removal of the larva from proconvulsant solution and were
continued for 10 min. Thus, EEG recordings were performed
consistently from min 20 through 30 following exposure to
PTZ (Figure 1). Recordings from eight or nine larvae were
taken per experimental condition. Epileptiform activity was
analyzed according to the duration of spiking paroxysms as
described previously [15]. Briefly, we compared the total
Locomotor vs. EEG Response in Zebrafish PTZ Assay
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number, the average duration and the cumulative duration of
epileptiform discharges in treated larvae. Spikes were
categorized as interictal-like (,3 s) or ictal-like (.3 s) [12]
with amplitudes exceeding three times the background noise
with the aid of Clampfit 10.2 software (Molecular devices
corporation, USA).
Statistical Analysis
Locomotor behavior data was first normalized against the
VHC+PTZ controls from the same tracking experiment and the
normalized data from replicate tracking runs subsequently pooled
together. AED+PTZ treatment groups were compared to
VHC+PTZ groups and VHC+medium groups using repeated
measures (mixed model) ANOVA. Both electrographic parameters
and the average total movement within 30 minutes were
compared using one-way ANOVA followed by Dunnett’s multiple
comparison test (GraphPad Prism software).
Results
Toxicological Evaluation
The maximum-tolerated concentrations (MTCs) of drugs
determined and used for further experiments are presented in
Table 1. Notably however, larvae treated with 300 mM LTG alone
were normal but displayed body distortions and became paralyzed
or died after addition of PTZ. Therefore, to avoid toxicity as a
result of the combination of these two compounds the experiment
was repeated with 100 mM LTG and this same concentration was
used for tectal field recordings. Vehicle-treated fish mostly escaped
before being touched, had normal heart rates, and displayed no
other signs of toxicity.
Proconvulsant Treatment
Zebrafish larvae exposed to PTZ exhibited signs of agitation
within seconds of contact with the proconvulsant. The larvae
swam along the periphery of the well (thigmotaxis), thus displaying
Stage I seizure-like behavior as described previously [5]. This was
succeeded by rapid ’whirlpool’-like movement, and then followed
by a short pause before swimming in a rapid, jerky manner with
Figure 1. Schematic comparison of the experimental timelines used for the behavioral tracking and EEG assays. Electrographic
recordings (EEG) are depicted in the upper portion, while locomotor tracking is depicted in the lower portion. Treatment parameters, order in which
they are applied and the key time-points for each experimental protocol are indicated by the arrows.
doi:10.1371/journal.pone.0054166.g001
Table 1. Comparison of AED activity in the zebrafish and rodent acute PTZ models.
AED Zebrafish locomotor assay Zebrafish EEG Rodent behavioral assay Rodent EEG
MTC Integration interval
30 min 5 min
Carbamazepine 100 mM – – – – [3,4,16,17,19,27] – [4]
Diazepam 16 mM – + + + [4,19] + [4]
Ethosuximide 10 mM – +/2 + + [4,16,19] + [4,18]
Gabapentin 25 mM – – – + [4,16], +/2 [3] + [4]
Lamotrigine 100 mM + – – – [16,19,21] – [28]
Levetiracetam 10 mM – +/2 – a – [16,19,21,29–32] +SWD [20]
Oxcarbazepine 250 mM – +/2 – + [17,19,33], – [3,16] NA
Phenytoin 100 mM – – – – [4,16,17,19,27] +/2 [4], – [27]
Primidone 750 mM – – – + [21] NA
Tiagabine 100 mM – – + + [16,19,33] NA
Topiramate 200 mM + + – +/2 [27], – [4,16,19,21] – [4]
Valproate 1 mM + + + + [4,16], – [19] + [4]
Zonisamide 300 mM – + – + [16,19], – [17] NA
Aspirin 50 mM – – –
An AED is indicated as positive for 30-min integration intervals if it significantly (p,0.05) decreased locomotor activity. We considered an AED positive (+) in the 5-min
time slices if there were one or more points significantly different from the PTZ-treated group (p,0.01 or better). Slight activity (+/2) was indicated when only one time
point was significantly lower (p,0.05) than the corresponding control point. a, spike-wave discharges (SWD) can not be directly measured in zebrafish tectal field
recordings; NA, data not available.
doi:10.1371/journal.pone.0054166.t001
Locomotor vs. EEG Response in Zebrafish PTZ Assay
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occasional body-stiffening and loss of posture (larva turning onto
its side or back). These events can be likened to tonic and clonic
seizure phases in mammals (Stages II-III) [7]. The working
concentration was defined as a concentration that induced a
significant increase in locomotor activity for the majority of larvae
tested within 30 min. We selected the concentration for PTZ at
20 mM for the behavioral test, which is in line with the effective
concentrations (15 mM, 20 mM) reported previously [5,7,9,15].
Movement increase upon PTZ exposure peaked at around 15 min
after the start of the experiment (Figure 2), and then continued for
at least another hour. Notably a decline in total larval movement
between 20 and 60 min was observed and is most likely due to the
majority of larvae spending more time in seizure stage III,
resulting in loss of posture and a consequent decrease in locomotor
activity. In addition, initial pilot experiments revealed that in the
first 15 min immediately after addition of PTZ, larval activity
levels are highly erratic, but become more uniform thereafter, as
the larvae start to undergo convulsions every minute or even more
frequently (Figure 2). Moreover, the addition of PTZ solution (or
vehicle) to the larvae and the transfer of the 96-well plate to the
tracking chamber acted as external stimuli and caused larvae to
initially become more active. Hence, for all subsequent experi-
ments, we allowed larvae to ‘habituate’ in the dark (except for the
infrared illumination required by the camera to capture larval
movements) for 5 min prior to the start of a tracking session.
Although, the level of larval activity is much more uniform 15 min
after addition of PTZ, we chose to commence tracking immedi-
ately after the 5 min habituation period because pilot experiments
also revealed that some AEDs were capable of significantly
reducing larval locomotor activity already within the first 5 min
after the start of the tracking session (Figure 3). Finally, tracking for
30 min was chosen for convenience, because longer exposure to
PTZ did not increase the level of locomotor activity compared to
controls further (signal to background ratios for 30 min and
1 hour periods were 9.4 and 8.5 respectively).
Test of AEDs in the Larval Zebrafish PTZ Assay
Out of a panel of thirteen commercially available AEDs tested
against PTZ, TPR (p,0.001), VPA (p,0.001), and LTG (p,0.05)
decreased PTZ-induced movement compared to VHC+PTZ
controls within the 30-min integration time, while GBP increased
this parameter (p,0.05). All other AEDs were not active at their
MTCs (Figure 3, Table 1).
However, a more detailed analysis of the 30-min tracking period
into 5-min intervals revealed the kinetics of the larval response to
PTZ more precisely (Figure 3). The rationale behind this type of
analysis was to detect transient effects or increased latency periods
for any of the tested AEDs, taking into consideration the fact that
the larvae are subjected to a continuous bath of PTZ throughout
the tracking assay (see Discussion). We considered an AED
positive if there were more than one point that showed a
statistically significant decline in total movement compared to the
VHC+PTZ treated group (Table 1, Figure 3). If there was only
one time point significantly (p,0.05) lower than the corresponding
control, the treatment was marked as slightly active (+/2). Using
this analysis method, DZP, TPR, VPA, and ZSM were considered
active in decreasing total larval movement while ETS, LVT, and
OXC were scored as slightly active (Table 1, Figure 3). With
regard to LTG, we observed a statistically significant increase in
larval locomotor activity within the first 5-min interval. However,
all other time-points showed no significant difference when
compared to VHC+PTZ-treated controls. Thus, using the 5-min
interval analysis method, LTG was scored as negative.
Figure 2. Behavioral profile of zebrafish larvae during a one-hour exposure to vehicle or PTZ. The average movement (y-axis) of vehicle-
and 20 mM PTZ-treated larvae are denoted by closed triangles (grey) and closed circles (black) respectively. The mean movement6 SD of 12 larvae is
depicted per minute (x-axis) of the tracking session. By 15 min, the frequency of convulsion-like episodes in all larvae reached a rate of one or more
per minute, which is reflected in the decrease in SD after this time point.
doi:10.1371/journal.pone.0054166.g002
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Tectal Field Recordings
The analysis of interictal-like electrographic activity after AED
exposure revealed that DZP, VPA and ZSM significantly
decreased the total number of interictal-like spikes. In addition,
the average duration of an interictal event was significantly
shortened by ETS, DZP and TGB (Figure 4).
DZP, ETS, TGB, and VPA dramatically decreased the number
of ictal discharges, as well as the total cumulative duration of all
types of epileptiform activity (Figure 5, Table 1). The average
duration of ictal spikes was significantly increased after exposure to
ZSM (Figure 5B). Other AEDs did not significantly change any of
the ictal discharge parameters analyzed (see Figure 6 for
representative time fragments of recordings of control and treated
larvae).
Discussion
In this study, we demonstrate that the larval zebrafish
behavioral response to PTZ, either alone or in combination with
AEDs, is largely indicative of changes in electrographic activity in
the brain. By aligning our findings in zebrafish with previously
reported rodent data on the effects of various AEDs in the acute
PTZ test, we also found a good correlation between zebrafish and
rodent data in both the behavioral and EEG assays.
DZP, ETS, VPA and TGB counteracted PTZ-evoked electro-
graphic seizures in both rodents [4,16–18] and zebrafish (our
data), while CBZ, LTG, PHT, and TPR were inactive in both
species [4,15,16,18,19, and our data]. DZP, ETS, and VPA also
inhibited convulsions in the locomotor tracking assay, while TGB
showed no activity. Thus, TGB turned out to be a false negative in
the zebrafish behavioral assay. The reason for this remains
unclear. One possibility is that TGB exerts additional peripheral
Figure 3. Behavioral profile of zebrafish larvae to AEDs. (A) The top graph depicts the average larval locomotor activity within 30 minutes (y-
axis) relative to VHC+PTZ (PTZ) control, as depicted by the average % 6 SEM; treatment groups where average movement was significantly
decreased compared to PTZ (one-way ANOVA) are marked *, **, and *** (p,0.05, p,0.01, and p,0.001, respectively). (B-O) The average total
movement (y-axis) of larvae treated with VHC only or PTZ with either VHC or AEDs. The average larval movement is depicted per 5 min interval (x-
axis) of the tracking session. Time points when the average movement was significantly decreased compared to PTZ control (repeated measures
ANOVA) are marked *, **, and *** (p,0.05, p,0.01, and p,0.001, respectively); standard errors are shown. F values (treatment group-dependent
variability): (A) 55.88, (B) 77.26, (C) 144.3, (D) 107.6, (E) 124.7, (F) 65.73, (G) 80.58, (H) 79.56, (I) 70.39, (J) 153.2, (K) 70.29, (L) 80.36, (M) 97.76, (N) 68.3, (O)
137.8. Total number of larvae used are indicated in brackets.
doi:10.1371/journal.pone.0054166.g003
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or off-target effects independent of its ability to suppress PTZ-
induced seizures. In contrast, LVT, TPR, OXC, and ZSM
inhibited seizure-like behavior in zebrafish larvae, but failed to
inhibit total seizure duration and/or frequency in the EEG
recordings. Notably, ZSM even worsened electrographic seizures.
We postulate that the observed decrease in larval locomotor
activity is due to a prolonged period wherein larvae remain in
seizure stage 3 [5]. In this seizure stage, larvae spend a good
portion of their time on their side or ‘belly up’ due to a loss of
balance. The end result is a general decrease in large movements.
A similar phenomenon is observed in rodents undergoing status
epilepticus where hardly any movement is observed, if at all. With
regard to LVT, it also failed to alter all EEG parameters in rodent
seizure assays, except for a slight reduction in spike wave
discharges [20], a parameter not measured in our study.
Nevertheless, our zebrafish EEG data correlate well with those
reported for mice by Watanabe et al. [4].
The results for LTG were rather ambiguous for the locomotor
assay. LTG exerted a mild but statistically significant (p,0.05)
activity in lowering PTZ-induced movement in the 30-minute
Figure 4. Quantitative analysis of interictal-like electrographic
activity in response to AEDs. (A) Total number of interictal-like
events within a 10-min recording (mean6SEM); (B) duration of
interictal-like events in seconds within a 10-min recording (mean6SEM).
Values that were significantly different from PTZ control were
determined using one-way ANOVA with *, ** and *** denoting
p,0.05, p,0.01 and p,0.001 respectively. The number of recordings
analysed were: VHC (n = 8), PTZ (n = 9), CBZ (n = 8), DZP (n = 8), ETS
(n = 9), GBP (n = 8), LTG (n = 8), LVT (n = 8), OXC (n = 8), PHT (n = 8), PMD
(n = 8), TGB (n = 8), TPR (n = 8), VPA (n = 8), ZSM (n= 8), ASP (n = 8); F
values (treatment group-dependent variability): (A) 4.298, (B) 6.602.
doi:10.1371/journal.pone.0054166.g004
Figure 5. Quantitative analysis of ictal-like electrographic
activity in response to AEDs. (A) Number of ictal-like events within
a 10-min recording (mean6SEM); (B) duration of ictal-like events within
a 10-min recording (mean6SEM); (C) total cumulative duration of all
types of epileptiform activity measured. Values that were significantly
different from PTZ control were determined using the one-way ANOVA
with *, ** and *** denoting p,0.05, p,0.01 and p,0.001 respectively.
The number of recordings analysed were: VHC (n = 8), PTZ (n = 9), CBZ
(n = 8), DZP (n = 8), ETS (n = 9), GBP (n = 8), LTG (n = 8), LVT (n = 8), OXC
(n = 8), PHT (n = 8), PMD (n= 8), TGB (n = 8), TPR (n = 8), VPA (n = 8), ZSM
(n= 8), ASP (n = 8). F values (treatment group-dependent variability): (A)
13.45, (B) 3.056, (C) 11.41.
doi:10.1371/journal.pone.0054166.g005
Locomotor vs. EEG Response in Zebrafish PTZ Assay
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Figure 6. Electrographic activity in zebrafish optic tecta: fragments of representative recordings. (A) Vehicle only; (B – P) 20 mM PTZ
with the following pre-treatment: (B) VHC; (C) CBZ; (D) DZP; (E) ETS; (F) GBP; (G) LTG; (H) LVT; (I) OXC; (J) PHT; (K) PMD; (L) TGB; (M) TPR; (N) VPA; (O)
ZSM; (P) ASP. Recordings were performed in current clamp mode, low-pass filtered at 1 kHz, high-pass filtered 0.1 Hz, digital gain 10, sampling
interval 10 ms.
doi:10.1371/journal.pone.0054166.g006
Locomotor vs. EEG Response in Zebrafish PTZ Assay
PLOS ONE | www.plosone.org 7 January 2013 | Volume 8 | Issue 1 | e54166
interval analysis, but came up consistently negative in the 5-min
interval analysis. Given that LTG was only ‘borderline’ positive in
the 30-min interval analysis, negative for the 5-min interval
analysis and negative in the EEG assay, then the overall
conclusion is that LTG is not active in the larval PTZ seizure
assay, a result that is perfectly in line with published rodent data
(see Table 1).
PMD and GBP did not inhibit PTZ-induced locomotor activity
in zebrafish larvae but were reported to be effective in the
equivalent rodent assays [4,21]. PMD is metabolized to pheno-
barbital and phenylethylmalonamide – both potent AEDs in
mammals [22]. A previous report by Baraban and colleagues
showed that phenobarbital was only mildly effective in suppressing
PTZ-evoked seizures in zebrafish [5]. PMD’s biotransformation
rate and pharmacokinetic profile in zebrafish larvae remains to be
determined – a general issue for all AEDs tested in zebrafish.
Although GBP contains a GABA moiety in its chemical
structure, it is instead thought to exert its antiepileptic activity
through the interaction with a2-d subunits of voltage-gated Ca2+
channels [22]. Voltage-gated Ca2+ channels have been cloned and
characterized in developing zebrafish [23,24], and are already
expressed and active within the first several days of development.
Thus, the fact that GBP was inactive in our assays may simply be
due to its hydrophilic properties as compounds with negative logP
values tend to be less active and/or poorly taken up in zebrafish
larvae [25,26, our own unpublished observations].
By administering AEDs at concentrations that on their own did
not cause locomotor impairment in zebrafish larvae, the total
number of AEDs shown to be active in the acute PTZ assay was
appreciably lower in comparison with the results of the previous
report by Berghmans and colleagues [7]. Admittedly, we used very
stringent criteria in the choice of AED concentrations, and this
difference most likely accounts for some of the discrepancies
observed. However, even in cases where the AED concentration
used was the same, we still observed differences in activity.
Furthermore, differences in the ability of several AEDs to induce
hypoactivity were also observed [7]. Although we followed very
similar protocols (e.g. overnight pre-treatment with AED before
addition of PTZ, same concentration of PTZ used, same assay
temperature 28.5uC applied, and AED pre-incubation, habitua-
tion period and tracking assay performed in complete darkness),
additional factors that may have influenced the outcome of our
study are: 1) strain differences (WIK, Berghmans; Ekkwill, our
study), 2) tracking software (Noldus, The Netherlands, Berghmans;
Viewpoint, France, our study), and 3) total tracking time (60 min,
Berghmans; 30 min, our study). With regard to strain differences,
pilot tests carried out while designing our experimental protocol
revealed that strain differences (Ekkwill vs. AB strain) and tracking
periods did not result in any significant changes in experimental
outcome.
On the other hand, we found a good correlation between our
EEG data and those reported by Baraban and colleagues
[5,25,26], despite differences in protocol, namely: 1) PTZ
concentration (15 mM PTZ, Baraban; 20 mM PTZ, our study),
2) Strains used (TL, Baraban; Ekkwill, our study), 3) Timing of
drug application (PTZ added before AED, Baraban; AED added
before PTZ, our study), and 4) Type of EEG parameter/s
evaluated (spike amplitude, Baraban; number and duration of
epileptiform discharges, our study). The single difference we
observed was in the case of ETS. This AED was reported by
Baraban and colleagues to be ineffective in decreasing spike
amplitude, whereas in our study we found it to significantly reduce
both the total number and duration of ictal-like discharges.
Nevertheless, a closer look at the EEG recordings we generated
from ETS-treated larvae show that spike amplitudes are also not
reduced (Figure 6B, 6E and data not shown). Despite major
differences in methodology, the results of our locomotor assays are
still largely in line with the EEG data generated in our study, with
those reported by Baraban and colleagues, and reported rodent
data.
Our findings indicate that the locomotor assay has more of a
tendency to pick up false positives rather than false negatives.
However, a much larger number of AEDs would have to be tested
in order to determine the true rate of false positives and false
negatives in this assay. Furthermore, the way in which total larval
movement is analyzed (i.e. 30-min versus 5-min tracking intervals,
can greatly influence experimental outcome, as transient or mild
activity of a drug or compound may be masked by combining total
activity over longer time periods. It must be emphasized that the
locomotor assay is useful as an initial indicator of potential
anticonvulsant activity, but that secondary assays such as EEG
recordings are warranted and would filter out false positives. The
development of improved software, in conjunction with faster
cameras for automated video tracking analysis, will enable the
recognition of more subtle seizure-specific behaviors (e.g. tremor
and loss-of-posture events), and improve the accuracy of seizure
recognition further. In addition, future development and applica-
tion of methods that address the pharmacokinetics of small
molecules in zebrafish larvae will be of value in the comparison of
results from different laboratories.
In summary, despite multiple differences – species, immature vs.
mature brain, uptake and metabolism - a good correlation
between zebrafish and rodent data was observed, underscoring
the biomedical relevance of the zebrafish PTZ seizure model.
Similar studies with other zebrafish seizure models will further
validate the predictive value of zebrafish for the in vivo discovery of
novel AEDs.
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